The first incontinence brief that tells you something is wrong.
LOO is a disposable adult brief with built-in UTI detection. A visible color change appears when nitrites are present in urine — giving long-term care teams an earlier signal, with zero new steps, devices, or training.
$250Bannual cost of unplanned U.S. hospitalizations
#1cause of LTC hospitalization is UTIs
0new devices, apps, or training
Visible indicator changes color when nitrites are detected.
The Problem
UTIs in older adults are missed — and it costs lives and billions.
#1
UTIs are the leading cause of hospitalizations in long-term care facilities.
~$250B
Unplanned hospitalizations cost the U.S. healthcare system every year.
Atypical
Older adults often present without classic UTI symptoms — confusion, agitation, or falls instead of pain.
“Early detection would eliminate these costs — but current solutions are expensive and too clunky to implement at scale.”
The Solution
A disposable brief with UTI detection built into the topsheet.
LOO looks and performs like a standard incontinence brief — but inside, stabilized nitrite chemistry turns a small external indicator a different color when a UTI marker is present.
Clean → urine present → nitrite-triggered color change. The same brief, before and after detection.
1
Urine enters the brief
Used exactly as a standard incontinence brief during a normal change cycle — no protocol changes.
2
Nitrites are detected
Stabilized chemistry integrated into the nonwoven reacts to nitrites, a known UTI biomarker.
3
Visible color change
An external indicator changes color — caregivers see it during the standard change and escalate per their protocol.
Manufactured as a full brief and compatible with existing production lines. Future scale through manufacturing partnerships.
Workflow
No disruption. No new devices. No training required.
Caregiver changes the briefExisting routine — no change.
Color change is visibleIndicator on the outside of the brief.
Staff escalate for clinical testingStandard facility protocol.
No new steps
No new devices
No training required
Seamless fit into existing care routines
Opportunity
A massive, underserved corner of elder care.
$4.5T+
U.S. institutional elder care market
$1T+
U.S. care continuum
$250B
U.S. elder care hospitalizations
85%
of UTI hospitalizations are female
Competitive Advantage
First to market in passive, integrated UTI detection.
First to market
Integrated passive UTI detection inside a disposable incontinence brief.
Ease of use
Functions like any standard brief — no caregiver behavior change.
Patent pending
Provisional filed: integration of nitrite chemistry into nonwoven.
High ROI
Designed to reduce avoidable hospitalizations and lab costs for facilities.
How LOO compares
Solution
Absorbent
Detects UTI biomarkers
Continuous
No workflow disruption
Standard briefs Essity, Kimberly-Clark, private label
✓
—
—
✓
UTI dipsticks Roche, Siemens
—
✓
—
—
Digital UTI sensors Academic concept
—
✓
✓
—
Symptom-based diagnosis
—
—
—
—
LOO
✓
✓
✓
✓
Go-to-Market & Business Model
B2B into nursing homes, priced to pay for itself.
Phase 1
Secure patent and tech
Lock in IP and finalize manufacturing-ready chemistry inside the brief.
Phase 2
Pilot with 3-star facilities
Convert early adopters and prove cost savings against avoidable hospitalizations.
Phase 3
Scale
License the technology to diaper manufacturers while expanding the LOO brand.
B2B sales into nursing homes through existing medical sales channels.
Sold as a fully integrated incontinence brief — not an add-on or device.
Premium per brief, justified by reduction in avoidable hospitalizations.
Behind LOO
Built by engineers and operators who have lived this problem.
Liz Tomon
Founder & CEO
Chemical engineer and MBA with 8+ years in engineering, manufacturing, and sales. Liz started LOO after seeing how often UTIs in older adults are missed until they become a hospitalization — and recognizing that the brief itself was the most overlooked place to catch them.
Joe Tomon
Technical Advisor
35+ years in manufacturing start-up operations. Currently CEO of Honeyville Grains.
Ron Matusiak
Technical Advisor
40+ years across paper and incontinence manufacturing operations.
Dr. Carolyn Carta
Chemist
PhD in materials science and chemistry. Worked across multiple industries before consulting for start-ups.
Contact
Let’s talk about a pilot.
Tell us a bit about your facility or interest and the LOO team will follow up with product, pricing, and pilot information.
